Corrie Pelc
Corrie Pelc reports on how new medical research reshapes understanding of chronic disease, with a steady focus on brain aging, metabolic health, and preventive strategies for Medical News Today. Her coverage links emerging treatments and lifestyle interventions to concrete outcomes such as dementia risk, diabetes remission, and weight maintenance. She writes study-led news features that quantify risk and benefit, foreground expert commentary, and keep the emphasis on what rigorous data shows for long-term health.
Brain aging, dementia risk, and prevention
Pelc devotes a large share of her reporting to how aging brains respond to vaccines, nutrients, blood pressure control, and hormone therapy. She covers work on memory decline beginning in middle age and on how intensive blood pressure management alters the seven-year risk of dementia, translating complex neurology and cardiology studies into clear numbers and timelines for cognitive change. Her piece on vitamin C and gray matter volume in aging adults fits this pattern, treating micronutrient research as part of the broader dementia-prevention landscape.
Alzheimer’s disease is a recurring anchor for her health beat.
She reports on high-dose influenza vaccination cutting Alzheimer’s risk by about 55% compared with standard-dose vaccination, reinforcing earlier data that multiple annual flu shots reduce risk by around 40%. She returns to diet as a modifiable factor, writing on whether there is a “best” diet to lower Alzheimer’s risk and summarizing a detailed review of Alzheimer’s-preventive eating patterns beyond single food groups. Her coverage of a cleared single-biomarker blood test for Alzheimer’s, as well as high-dose vitamin D for brain health in older adults at risk of dementia, shows how she tracks both diagnostic innovation and everyday interventions across the same disease space.
Hormones and life stage are part of this brain-health line. Pelc writes on how menopause subtype and hormone therapy timing influence dementia risk, connecting gynecologic research to cognitive outcomes and showing that women’s health decisions carry long arc neurological implications. Throughout these pieces, she consistently situates findings within global prevalence data, noting tens of millions of people living with dementia and emphasizing why incremental percentage changes in risk matter at population scale.
Metabolic health, diabetes, and lifestyle interventions
Metabolic disease and weight management form another core strand of Pelc’s reporting, where she moves between pharmaceuticals, diet, and daily routines. She covers a phase 2b trial of the oral GLP-1 drug elecoglipron, detailing how different dosages improve blood glucose and HbA1c levels in people with type 2 diabetes and how large proportions of participants achieve clinically meaningful weight loss.
In a separate article, she reports that combining an SGLT-2 inhibitor such as dapagliflozin with moderate calorie restriction raises diabetes remission rates from 28% to 44% compared with diet alone, spelling out remission percentages and relative improvements with precision.
Diet composition and timing appear frequently. Pelc writes about keto versus low-fat eating for diabetes remission, explaining that while both approaches lead to weight loss, keto produces stronger changes in proinsulin secretion and beta-cell function, which she links directly to remission outcomes.
She covers time-restricted eating research showing earlier and mid-day eating windows deliver better results for weight, waist circumference, blood pressure, and fasting glucose than late-day windows. Across these pieces she keeps trial design, sample size, and duration visible, making clear how robust each conclusion is and under what conditions it applies.
Everyday activity features alongside diet and drugs. Pelc reports on a study indicating that walking about 8,500 steps a day helps people maintain weight loss after dieting, outlining how increased steps during a lifestyle program yielded roughly 4.4% weight loss and how continuing near that level preserved about three-quarters of the loss over time.
She also covers work showing that 99% of heart attack, stroke, and heart failure cases occur in people with at least one of four major cardiovascular risk factors above ideal levels - high blood pressure, cholesterol, fasting glucose, or tobacco use - linking this to both South Korean and U.S. population datasets. Her metabolic reporting consistently ties clinical findings back to modifiable behaviors and clear numeric thresholds.
GLP-1 medications, obesity, and musculoskeletal health
Pelc treats GLP-1 drugs as a cross-cutting topic that spans obesity, orthopedics, bone health, and rheumatology. Beyond new agents like elecoglipron, she writes on what happens when widely used GLP-1s such as Wegovy do not deliver expected weight outcomes and explores practical options for people in that situation.
Her coverage of postmenopausal weight loss shows how pairing menopausal hormone therapy with tirzepatide leads to about 35% more weight loss than tirzepatide alone, underscoring the way she examines combination regimens rather than single agents in isolation.
She regularly examines the systemic effects of GLP-1s. One article explains that most weight loss from GLP-1 medication comes from fat rather than muscle, with only modest lean mass loss over three months and substantial reductions in visceral fat after 12 months. Another reports that GLP-1 use is linked to higher risks of osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, while also noting findings that GLP-1s improve postoperative outcomes in certain orthopedic procedures.
Pelc uses these studies to frame GLP-1s as drugs with both protective and adverse musculoskeletal effects, requiring a nuanced risk–benefit view.
Her rheumatology coverage extends this lens. She writes on the discovery of endogenous GLP-1 in synovial (joint) fluid and how this opens up potential new arthritis treatment strategies. She reports on rheumatoid arthritis’s two-way relationship with depression and other conditions, highlighting that some comorbidities do not simply follow arthritis but help maintain difficult-to-treat disease. In related work, she covers an arthritis drug under study for regrowing up to 80% of hair in alopecia areata, showing interest in how immunomodulatory agents can be repurposed across inflammatory and autoimmune disorders.
Cardiovascular disease and broader chronic conditions
Cardiovascular risk runs through much of Pelc’s wider reporting, often intersecting with metabolic, infectious, and aging themes. She covers how a shingles vaccine is associated with a 9% reduction in cardiovascular burden, presenting it as one of several preventive strategies that sit at the intersection of infectious disease and heart health. She reports on a natural compound derived from pomegranates that may improve heart function in people with heart failure, setting the finding against estimates that around 64 million people worldwide have heart failure and emphasizing the scale of potential impact.
Her work on AI-designed drugs targeting lung disease and biological aging markers further illustrates a focus on emerging modalities for chronic conditions. Across cardiovascular and multi-system topics, Pelc repeatedly brings large epidemiologic datasets into her stories, citing cohorts of millions of adults when describing risk factor prevalence or intervention effects.
The result is coverage that keeps both individual clinical detail and population-level burden in view, giving her chronic-disease reporting a quantitatively grounded, forward-looking character.
4 more health journalists.
Aislinn Antrim
Aislinn Antrim is an associate editorial director at Pharmacy Times and a journalist who connects clinical advances, regulation, and the changing role of pharmacists. She writes pharmacy-centered health coverage on chronic disease therapeutics, specialty and oncology care, workforce pressures, and advocacy. Her reporting explains FDA actions, policy shifts, drug pipelines, and the real-world effects of new evidence on patient care and pharmacy practice. She often uses interviews and expert conversations to show how pharmacists improve adherence, manage side effects, navigate access and benefits, and coordinate care with prescribers. She also covers burnout, staffing strain, and the future of pharmacy practice, with an eye on how policy and economics shape work at the dispenser.
Alex Cabrero
Alex Cabrero is an Emmy award-winning KSL TV reporter who covers where health, safety and community life meet, always focused on how decisions and events affect everyday people. He has been with KSL since 2004, bringing long experience in breaking news, public service coverage and human-centered features. His beat includes public health, emergency response, technology, local infrastructure, environment and science, framed through community well-being and resilience. He reports on issues like mental health initiatives, law enforcement staffing, environmental hazards, rescues, wildfire detection tools, land-use fights and scientific discoveries, making technical and policy details clear for a general audience. He also produces many positive, everyday-life features on families, veterans, farmers, sports and local traditions. His style is direct and conversational, often built around a central person or family whose experience carries the story across TV, digital and social platforms.
Alexandra Frost
Alexandra Frost is a freelance journalist and content marketing writer who turns expert-backed health and family guidance into clear, practical service stories. She covers consumer health, wellness, nutrition, preventive care, medical research, parenting, kids’ mental health, education, products, and lifestyle. Her reporting explains concerns such as inflammation, urinary symptoms, fiber, lung cancer screening, pain treatment, mobility, family dynamics, children’s technology use, and school readiness. She profiles clinicians and scientists, connects research to everyday decisions, and focuses on what readers should watch for, ask, or change. Frost currently writes across multiple outlets, including Good Housekeeping, Cincinnati Magazine, Wirecutter, Popular Science, Success, Healthline, Parents, Women’s Health, Reader’s Digest, Today’s Parent, the Atlantic, the Washington Post, TIME, Consumer Reports, Business Insider, and National Geographic. She also works as a freelance editor, media consultant, and content strategist.
Alexandra Pattillo
Alexandra Pattillo is a freelance journalist who pairs rigorous health and science reporting with intimate accounts of patients’ lives. She covers health, science and wellness for the BBC and other major outlets, including National Geographic, The New York Times, The Atlantic, The Guardian, Outside, CNN and Inverse. Her beat includes eating disorders, women’s health, perinatal mental health, brain health, youth sports, concussion, long-term Covid symptoms, attention, habits and behavioral science. She reports on emerging treatments such as psychedelic-assisted therapy for anorexia, testing evidence, safety and relapse risk. She explains complex research in plain language and examines how it shapes everyday choices. Her reporting uses in-depth interviews with patients, families, clinicians, researchers and coaches. Through the BBC’s Health Gap column, she also covers stigma, unequal access to care and gaps between lived experience and standard medical pathways.